Plus Therapeutics, Inc. (PTSC) Stock Price on the Rise as RNL Gains Traction
Plus Therapeutics, Inc. (PTSV) stock prices were up an impressive 16.5% as of market close on April 21st, 2021, bringing the price per share up to USD$2.33. Strong 2020 Reported Despite Pandemic Q2 2020 saw PSTV’s radiotherapeutic platform and an array of investigational drugs being in-licensed, as well as the substantial clinical progress for the […]
Newly Listed Movano Inc (MOVE) Stock Price Experience Volatility
Movano Inc. (MOVE) stock prices were down to USD$5.50 after having experienced a 2.65% decline as of the market close on April 16th, 2021. Subsequent pre-market fluctuations saw the price further fall to USD$5.30, a decrease of 3.64%. Public Offering Right Out the Gate The health technology company began trading on the Nasdaq Capital Market […]
Timber Pharmaceuticals, Inc (TMBR) Stock Price Fall Despite a Lack of Negative Press
April 16th, 2021 has seen Timber Pharmaceuticals, Inc. (TMBR) stock prices experience a sharp decline of more than 14%, dropping down to USD$1.5192. TMBR at the End of 2020 Financial reports for the fiscal year ending December 31st, 2020 were announced by TMBR near the end of March 2021. The CEO reported progress on all […]
Can Nxt-ID, Inc. (NXTD) Stock Continue Clinging to Nasdaq Compliance?
Nxt-ID, Inc. (NXTD) stock prices are down 8.77% as of April 15th, 2021, coming to a rest at USD$1.04 as of the market close. With stock prices having displayed the typical volatility associated with penny stocks, investors are keeping a close eye on NXTD. What is Nxt-ID? The provider of tech products and services for […]
Why did PPD Inc. (PPD) Stock rise in Premarket?
PPD, Inc. (PPD) stock prices soared on April 14th, 2021, seeing a surge of 12.1% to place the stock at an all-time high of USD$43. Pre-market fluctuation saw the stock increase by 6.49% to reach highs of USD$45.80. Acquisition by Thermo Fisher Scientific This sudden spike in PPD stock prices follows news of the company […]
ContraFect Corporation (CFRX) Stock Could See Substantial Growth with Impressive Capital Generation
ContraFect Corporation (CFRX) hit USD$4.11 at market close on April 14th, 2021, having seen an upswing of 4.05%. Investors hope this is a continuation of growth in stock prices that will continue its upward trend. BARDA Contract CFRX stock prices saw a sharp spike following the announcement of a USD$86.8 million contract with the Biomedical […]
InspireMD, Inc. (NSPR) Stock Trends Upwards After a Troubling 2020
Up 0.38% as of market close on April 14th, 2021, InspireMD, Inc. (NSPR) sat at USD$0.5538. This came hot on the heels of news of a 1-for-15 reverse split of NSPR’s common stock. This change will come into effect on April 26th, 2021, and will result in a reduced number of outstanding shares of its […]
Is the Sky the Limit For Fortress Biotech, Inc (FBIO) Stock?
Fortress Biotech, Inc. (FBIO) stock prices saw a 0.7% increase at market close, situating it at USD$5.48. This is the continuation of a consistent and gradual increase in FBIO stock price, with a more pronounced increase recently following certain developments. Acquisition of QBREXZA Journey Medical Corporation, a partner company of FBIO, announced at the start […]
Will iRhythm Technologies, Inc (IRTC) Stock Collapse Because of Fraud Allegations?
iRhythm Technologies, Inc. (IRTC) saw a staggering 37.9% crash over the weekend after the market closed on April 9th, 2021. As of April 12th, 2021, IRTC sits at USD$82.44. This development coincides with the unfolding of a class action lawsuit against IRTC and some of its executive management team. What did IRTC do Wrong? The […]
Will Nuance Communications, Inc (NUAN) and Microsoft Tackle the Healthcare Sector Together?
Having closed on April 9th, 2021 at USD$45.58, Nuance Communications, Inc (NUAN) has seen a pre-market surge of more than 22 to hit just under USD$56 per share. This followed the news that Microsoft would be buying NUAN for an astounding USD$16 billion. History of Microsoft and NUAN’s partnership Microsoft and NUAN have been working […]
